Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Dr. Reddy s Laboratories Limited (NSE: DRREDDY)

 
DRREDDY Technical Analysis
2
As on 25th Apr 2024 DRREDDY SHARE Price closed @ 6218.75 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 5621.47 & Sell for SHORT-TERM with Stoploss of 6219.86 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DRREDDYSHARE Price

Open 5975.05 Change Price %
High 6262.00 1 Day 267.95 4.50
Low 5928.00 1 Week 261.60 4.39
Close 6218.75 1 Month 15.55 0.25
Volume 926985 1 Year 1385.45 28.66
52 Week High 5953.35 | 52 Week Low 3880.00
 
DRREDDY CURRENT MONTH FUTURE
Close 6220.50
Contracts Traded 1112250
Open Intrest 123125
Change In O.I -80.83 %
Lot Size 125
DRREDDY CURRENT MONTH OPTION
Most Active Call 6200.00
Most Active put 6100.00
Highest O.I Buildup Call 6100.00
Highest O.I Buildup Put 6100.00
Expiry Date 2024-04-25
DRREDDY ALL MONTHS OPTIONS
For All DRREDDY Options Click Here
 
NSE INDIA Most Active Stocks
IDEA 13.90 6.11%
YESBANK 25.95 1.96%
KOTAKBANK 1642.45 -10.87%
SOUTHBANK 30.40 4.47%
SAIL 164.95 0.18%
PNB 135.90 2.18%
TATASTEEL 167.70 1.30%
AXISBANK 1127.00 6.00%
IRFC 150.25 0.84%
IOB 66.90 5.77%
 
NSE INDIA Top Gainers Stocks
ROML 75.65 19.98%
POWERINDIA 9329.50 13.60%
GPTINFRA 211.80 12.51%
NEOGEN 1557.75 12.25%
PNC 65.00 11.02%
PNC 65.00 11.02%
PNC 65.00 11.02%
PNC 65.00 11.02%
MOIL 430.70 10.88%
GODFRYPHLP 3449.70 10.17%
 
NSE INDIA Top Losers Stocks
KOTAKBANK 1642.45 -10.87%
GLS 750.50 -9.20%
EXCEL 0.50 -9.09%
DALBHARAT 1806.45 -7.97%
WEIZMANIND 132.50 -6.85%
5PAISA 536.35 -6.77%
CELEBRITY 19.85 -6.59%
BBL 3135.00 -5.60%
BBL 3135.00 -5.60%
BBL 3135.00 -5.60%
 
 
DRREDDY
Daily Charts		 DRREDDY
Intraday Charts		 Whats New @
Bazaartrend		 DRREDDY
Free Analysis
 
DRREDDY Important Levels Intraday
RESISTANCE6862.37
RESISTANCE6655.96
RESISTANCE6528.37
RESISTANCE6400.78
SUPPORT6036.72
SUPPORT5909.13
SUPPORT5781.54
SUPPORT5575.13
 
DRREDDY Target April 2024
Share
4th UP Target8092.13
3rd UP Target7483.24
2nd UP Target7106.88
1st UP Target6730.51
1st DOWN Target5656.59
2nd DOWN Target5280.22
3rd DOWN Target4903.86
4th DOWN Target4294.97
 
DRREDDY Weekly Target
4th UP Target6616.14
3rd UP Target6400.21
2nd UP Target6266.74
1st UP Target6133.27
1st DOWN Target5752.43
2nd DOWN Target5618.96
3rd DOWN Target5485.49
4th DOWN Target5269.56
 
DRREDDY Target2024
4th UP Target9637.83
3rd UP Target8406.34
2nd UP Target7645.13
1st UP Target6883.92
1st DOWN Target4711.88
2nd DOWN Target3950.67
3rd DOWN Target3189.46
4th DOWN Target1957.97
 
 
DRREDDY Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
 Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is 26.90 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 3152.68
10 Day Avg Volume Traded -18.28 % Less then 10 Day Average Volume
 
DRREDDY Other Details
Segment EQ
Market Capital 777352314880.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
DRREDDY Address
DRREDDY
 
DRREDDY Latest News
 
Your Comments and Response on Dr. Reddy s Laboratories Limited
 
DRREDDY Business Profile
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Proprietary Products segment focuses on the research, development, and commercialization of differentiated formulations for dermatology and neurology therapeutic areas. The Others segment engages in developing therapies in the fields of oncology and inflammation. As of March 31, 2021, it had three late stage projects at various stages of development. Its therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Address: 8-2-337, Road No. 3, Hyderabad, India, 500034
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service